PBA
CERE
Paradigm Biocapital Advisors’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-2,330,508
| Closed | -$95.3M | – | 42 |
|
|
2024
Q2 | $95.3M | Hold |
2,330,508
| – | – | 3.65% | 9 |
|
|
2024
Q1 | $98.5M | Hold |
2,330,508
| – | – | 3.47% | 12 |
|
|
2023
Q4 | $98.8M | Sell |
2,330,508
-202,464
| -8% | -$8.58M | 4.63% | 9 |
|
|
2023
Q3 | $55.3M | Buy |
2,532,972
+664,026
| +36% | +$14.5M | 3.75% | 13 |
|
|
2023
Q2 | $59.4M | Buy |
1,868,946
+273,747
| +17% | +$8.7M | 4.59% | 6 |
|
|
2023
Q1 | $38.9M | Buy |
+1,595,199
| New | +$38.9M | 3.69% | 14 |
|